168 related articles for article (PubMed ID: 16149597)
1. [Carcinoembryonic antigen (CEA)].
Kinugasa T; Kuroki M
Nihon Rinsho; 2005 Aug; 63 Suppl 8():632-4. PubMed ID: 16149597
[No Abstract] [Full Text] [Related]
2. [Evaluation of the measurement of serum carcinoembryonic antigen (CEA) levels using monoclonal antibody].
Yoneshima M; Sawabu N; Kidani H; Takemori Y; Toya D; Okai T; Hattori N; Ogino T; Mai M
Gan No Rinsho; 1985 Aug; 31(10):1311-7. PubMed ID: 4057566
[TBL] [Abstract][Full Text] [Related]
3. [Serum level of tumor markers (antigen Ca 19-9, CEA, ferritin) in digestive tumors. Their diagnostic usefulness].
Jovin G; Stănel I; Popovici I; Oproiu A
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(3):223-9. PubMed ID: 2904162
[No Abstract] [Full Text] [Related]
4. [Clinical significance of Span-1 antigen assay as a tumor marker].
Satake K; Chung YS; Umeyama K
Nihon Rinsho; 1990 Feb; 48 Suppl():1053-6. PubMed ID: 2355504
[No Abstract] [Full Text] [Related]
5. [The concentration of carcinoembryonic antigen and carbohydrate antigen Ca-19-9 in the blood serum in cancerous diseases of the gastrointestinal tract].
Mit'kov VV; Ogneva TV; Goriaĭnova II; Milanov S; Milkov V
Med Radiol (Mosk); 1989 Nov; 34(11):22-4. PubMed ID: 2586258
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of a new serum marker of human digestive cancer: the carbohydrate antigen 19.9; comparison with the carcinoembryonic antigen].
Olsson NO; Crimet-Montange D; Martin F
Gastroenterol Clin Biol; 1985 Mar; 9(3):206-11. PubMed ID: 3859449
[TBL] [Abstract][Full Text] [Related]
7. [Fundamental and clinical evaluation of immunoradiometric assay (IRMA) for serum pancreatic oncofetal antigen (POA)].
Ohba N; Hashimoto T; Nishibu M; Kashiwaya Y; Kawai K; Matsubara F; Miyazaki I
Rinsho Byori; 1989 Feb; 37(2):153-8. PubMed ID: 2733181
[No Abstract] [Full Text] [Related]
8. Evaluation of a new monoclonal radioimmunoassay system for carcinoembryonic antigen.
Matsuoka Y; Kuroki M; Okamoto N; Ikeda S; Hara Y; Minamizawa T; Tachibana S; Ogawa H; Tabata N
Jpn J Clin Oncol; 1988 Jun; 18(2):97-103. PubMed ID: 2454336
[TBL] [Abstract][Full Text] [Related]
9. [Oncologic markers in the diagnosis of malignant tumors of the digestive tract].
Maĭstrenko NA; Kurygin AA; Khrykov GN
Vestn Khir Im I I Grek; 2002; 161(4):102-6. PubMed ID: 12577567
[No Abstract] [Full Text] [Related]
10. Carcinoembryonic antigen fraction in digestive cancer.
Fong S; García Vega G; León V
Neoplasma; 1985; 32(2):199-208. PubMed ID: 4000309
[TBL] [Abstract][Full Text] [Related]
11. Use of immunologic tumor markers in body fluid analysis.
Kjeldsberg CR; Marty J
Clin Lab Med; 1985 Jun; 5(2):233-64. PubMed ID: 3896624
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells.
Hampton R; Walker M; Marshall J; Juhl H
Oncogene; 2002 Nov; 21(51):7817-23. PubMed ID: 12420218
[TBL] [Abstract][Full Text] [Related]
13. [Carcinoembryonic antigen (CEA) in ascites].
Coenen C; Schmidt G; Wegener M; Wedmann B; Bauer KH; Ricken D
Fortschr Med; 1991 Apr; 109(13):280-2. PubMed ID: 2066045
[TBL] [Abstract][Full Text] [Related]
14. Carcinoembryonic antigen in effusions. A diagnostic adjunct to cytology.
Pinto MM; Bernstein LH; Brogan DA; Criscuolo EM
Acta Cytol; 1987; 31(2):113-8. PubMed ID: 3548190
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic evaluation of alanine aminopeptidase as serum marker for detecting cancer.
Severini G; Gentilini L; Tirelli C
Cancer Biochem Biophys; 1991 Nov; 12(3):199-204. PubMed ID: 1688253
[TBL] [Abstract][Full Text] [Related]
16. CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancer.
Hasholzner U; Stieber P; Reiter W; Zimmermann A; Hofmann K; Schalhorn A
Anticancer Res; 1999; 19(4A):2477-80. PubMed ID: 10470177
[TBL] [Abstract][Full Text] [Related]
17. [CEA studies in endometrial cancer].
Kunze M; Voss P; Büttner HH; Strache RR; Wagner M; Röpcke G
Zentralbl Gynakol; 1989; 111(8):524-9. PubMed ID: 2741592
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of 2-6 sialyl Le(a) antigen assay as a tumor marker].
Kannagi R; Itai S; Harada R
Nihon Rinsho; 1990 Feb; 48 Suppl():1045-52. PubMed ID: 2355503
[No Abstract] [Full Text] [Related]
19. Urinary gonadotropin peptide in patients with cancer of digestive organs.
Motoo Y; Watanabe H; Yamaguchi Y; Mouri I; Fujii T; Yamakawa O; Satomura Y; Okai T; Sawabu N
Anticancer Res; 1996; 16(4A):2041-8. PubMed ID: 8712740
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of carbohydrate antigen 19-9 assay as a tumor marker].
Ohkura H; Sakawaki T; Hara K; Mitsuhashi F
Nihon Rinsho; 1990 Feb; 48 Suppl():931-3. PubMed ID: 2192177
[No Abstract] [Full Text] [Related]
[Next] [New Search]
